269 related articles for article (PubMed ID: 14688580)
21. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
Sambatakou H; Dupont B; Lode H; Denning DW
Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
[TBL] [Abstract][Full Text] [Related]
22. Fatal invasive trichosporonosis due to Trichosporon loubieri in a patient with T-lymphoblastic lymphoma.
Gabriel F; Noel T; Accoceberry I
Med Mycol; 2011 Apr; 49(3):306-10. PubMed ID: 20950223
[TBL] [Abstract][Full Text] [Related]
23. Acanthamoeba infection in a patient with chronic graft-versus-host disease occurring during treatment with voriconazole.
Kaul DR; Lowe L; Visvesvara GS; Farmen S; Khaled YA; Yanik GA
Transpl Infect Dis; 2008 Dec; 10(6):437-41. PubMed ID: 18713138
[TBL] [Abstract][Full Text] [Related]
24. Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
Asada N; Uryu H; Koseki M; Takeuchi M; Komatsu M; Matsue K
Clin Infect Dis; 2006 Aug; 43(4):e39-41. PubMed ID: 16838224
[TBL] [Abstract][Full Text] [Related]
25. Fatal cerebral zygomycosis breakthrough in a patient with acute lymphoblastic leukemia on voriconazole prophylaxis after cord blood SCT.
Vande Broek I; Schots R
Bone Marrow Transplant; 2009 Dec; 44(11):765-6. PubMed ID: 19421169
[No Abstract] [Full Text] [Related]
26. Voriconazole plasma monitoring.
Pasqualotto AC; Shah M; Wynn R; Denning DW
Arch Dis Child; 2008 Jul; 93(7):578-81. PubMed ID: 18252755
[TBL] [Abstract][Full Text] [Related]
27. Fungemia and renal fungus ball formation with Candida norvegensis in a child with acute lymphoblastic leukemia.
Kurucu N; Kul S; Tosun I; Erduran E; Köksal I
Turk J Pediatr; 2011; 53(4):448-51. PubMed ID: 21980850
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary aspergillosis caused by a pan-azole-resistant Aspergillus fumigatus in a 10-year-old boy.
Thors VS; Bierings MB; Melchers WJ; Verweij PE; Wolfs TF
Pediatr Infect Dis J; 2011 Mar; 30(3):268-70. PubMed ID: 21127455
[TBL] [Abstract][Full Text] [Related]
29. Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.
Slobbe L; Polinder S; Doorduijn JK; Lugtenburg PJ; el Barzouhi A; Steyerberg EW; Rijnders BJ
Clin Infect Dis; 2008 Dec; 47(12):1507-12. PubMed ID: 18990068
[TBL] [Abstract][Full Text] [Related]
30. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.
Imhof A; Balajee SA; Fredricks DN; Englund JA; Marr KA
Clin Infect Dis; 2004 Sep; 39(5):743-6. PubMed ID: 15356792
[TBL] [Abstract][Full Text] [Related]
31. Angioinvasive pulmonary aspergillosis.
Arbona GA; Tarver RD; Conces DJ
Semin Respir Infect; 2000 Jun; 15(2):178-82. PubMed ID: 10983934
[No Abstract] [Full Text] [Related]
32. Combination therapy with caspofungin and liposomal amphotericin B for invasive aspergillosis.
Elanjikal Z; Sörensen J; Schmidt H; Dupuis W; Tintelnot K; Jautzke G; Klingebiel T; Lehrnbecher T
Pediatr Infect Dis J; 2003 Jul; 22(7):653-6. PubMed ID: 12867844
[TBL] [Abstract][Full Text] [Related]
33. Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases.
Mouas H; Lutsar I; Dupont B; Fain O; Herbrecht R; Lescure FX; Lortholary O;
Clin Infect Dis; 2005 Apr; 40(8):1141-7. PubMed ID: 15791514
[TBL] [Abstract][Full Text] [Related]
34. Esophagomediastinal and esophagobronchial fistulas associated with invasive aspergillosis.
Kato S; Inoue S; Inamori M; Miyazawa N; Sato T; Kobayashi N; Mishina K; Sasaki M; Ishigatsubo Y; Nakajima A
Endoscopy; 2010; 42 Suppl 2():E48-9. PubMed ID: 20157886
[No Abstract] [Full Text] [Related]
35. Two cases of cerebral aspergillosis successfully treated with voriconazole.
de Lastours V; Lefort A; Zappa M; Dufour V; Belmatoug N; Fantin B
Eur J Clin Microbiol Infect Dis; 2003 May; 22(5):297-9. PubMed ID: 12740666
[TBL] [Abstract][Full Text] [Related]
36. Improving the outcome of invasive aspergillosis: new diagnostic tools and new therapeutic strategies.
Herbrecht R
Ann Hematol; 2002; 81 Suppl 2():S52-3. PubMed ID: 12611078
[No Abstract] [Full Text] [Related]
37. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
Berge M; Guillemain R; Boussaud V; Pham MH; Chevalier P; Batisse A; Amrein C; Dannaoui E; Loriot MA; Lillo-Le Louet A; Billaud EM
Transpl Infect Dis; 2009 Jun; 11(3):211-9. PubMed ID: 19302272
[TBL] [Abstract][Full Text] [Related]
38. Sequential or combination antifungal therapy with voriconazole and liposomal amphotericin B in a Guinea pig model of invasive aspergillosis.
Kirkpatrick WR; Coco BJ; Patterson TF
Antimicrob Agents Chemother; 2006 Apr; 50(4):1567-9. PubMed ID: 16569887
[TBL] [Abstract][Full Text] [Related]
39. Successful treatment of disseminated fusariosis with voriconazole in an acute lymphoblastic leukaemia patient.
Labois A; Gray C; Lepretre S
Mycoses; 2011 Dec; 54 Suppl 4():8-11. PubMed ID: 22126523
[TBL] [Abstract][Full Text] [Related]
40. Clinical use and tolerability of voriconazole in the treatment of fungal infections in critically ill patients.
Alvarez-Lerma F; Nicolás-Arfelis JM; Rodríguez-Borregán JC; Díaz-Regañón J; Sa-Borges M; García-López F; Allepuz-Palau A
J Chemother; 2005 Aug; 17(4):417-27. PubMed ID: 16167522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
